Description:

DEPRECATED old version

Keywords:
Versions (1) ▾
  1. 12/11/13
Uploaded on:

December 11, 2013

DOI:
No DOI assigned. To request one pleaselog in.
License:
Creative Commons BY-NC 3.0 Legacy
Model comments:

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for:

Item comments for:

In order to download data models you must be logged in. Please log in or register for free.

Eligibility NCT00071084 T-Cell Lymphoma

Eligibility

  1. StudyEvent: Eligibility
    1. Eligibility
Inclusion criteria
Medical diagnosis of CTCL, and positivity for the CD4 receptor
Late stage CTCL
Have received at least one prior anti-cancer therapy with inadequate effect
WHO performance status 0,1 or 2
Age 18 or older
Exclusion criteria
Certain rare types of CTCL
Previous treatment with other anti-CD4 medications
More than two previous treatments with systemic chemotherapy
Certain anti-psoriasis or anti-cancer therapies within the last 4 weeks before entering this trial
Some types of steroid treatments less than two weeks before entering the trial
Prolonged exposure to sunlight or UV light during the trial
Other cancer diseases, except certain skin cancers or cervix cancer
Chronic infectious disease requiring medication
Certain serious medical conditions, including kidney or liver disease, some psychiatric illnesses, and stomach, lung, heart, hormonal, nerve or blood diseases
Certain laboratory values which are too high or too low
HIV positivity
Pregnant or breast-feeding women
Women of childbearing age who are unable or unwilling to use an IUD or hormonal birth control during the whole trial
If you are participating in another trial with a different new drug 4 weeks before you enter this trial